Chemotherapy of medulloblastoma

Medical and Pediatric Oncology

Volumn 33, Issue 2, 1999, Pages 116-119

  Mastrangelo, Stefano ^a   Tornesello, Assunta ^a   Mastrangelo, Renato ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Brain tumors; Chemotherapy; Childhood cancer; Medulloblastoma; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; BUSULFAN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; ETOPOSIDE; HYDROXYUREA; MELPHALAN; METHOTREXATE; PROCARBAZINE; THIOTEPA; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; BLOOD BRAIN BARRIER; CANCER COMBINATION CHEMOTHERAPY; CHILDHOOD CANCER; DRUG EFFICACY; DRUG PENETRATION; DRUG SCREENING; HUMAN; MEDULLOBLASTOMA; PRIORITY JOURNAL; REVIEW; CEREBELLUM TUMOR; CHILD;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD-BRAIN BARRIER; CEREBELLAR NEOPLASMS; CHILD; HUMANS; MEDULLOBLASTOMA;

EID: 0032814471     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(199908)33:2<116::AID-MPO11>3.0.CO;2-E     Document Type: Review

References (20)

1. Moghrabi A, Fuchs H, Brown M, et al. Cyclophosphamide in combination with sargramostim for treatment of recurrent medulloblastoma. Med Ped Oncol 1995;25:190-196.
2. Allen JC, Helson L. High-dose cyclophosphamide chemotherapy for recurrent CNS tumors in children. J Neurosurg 1981;55:749-756.
3. Mastrangelo R, Lasorella A, Riccardi R, et al. Carboplatin in childhood medulloblastoma/PNET: feasibility of an in vivo sensitivity test in an "up-front" study. Med Ped Oncol 1995;24:188-196.
4. Mastrangelo R, Lasorella A, Tornesello A, Riccardi R. Carboplatin and cisplatin in medulloblastoma at diagnosis: "comparable efficacy?" (letter). J Clin Oncol 1996;14:1741.
5. Boor R, Huber A, Gutjahr P, et al. Etoposide treatment in recurrent medulloblastoma. Neuropediatrics 1994;25:39-41.
6. Finn GP, Bozek T, Souhami RL, et al. High-dose etoposide in the treatment of relapsed primary brain tumors. Cancer Treat Rep 1985;69:603-605.
7. Ashley DM, Meier L, Kerby T, et al. Response of recurrent medulloblastoma to low-dose oral etoposide. J Clin Oncol 1996;14: 1922-1927.
8. Davidson A, Gowing R, Lowis S, et al. Phase II study of 21 day schedule oral etoposide in children. Eur J Cancer 1997;33:1816-1822.
9. Needle MN, Molloy PT, Geyer JR, et al. Phase II study of daily oral etoposide in children with recurrent brain tumors and other solid tumors. Med Ped Oncol 1997;29:28-32.
10. Dupuis-Girod S, Hartmann O, Benhamou E, et al. Will high dose chemotherapy followed by autologous bone marrow transplantation supplant cranio-spinal irradiation in young children treated for medulloblastoma? J Neurooncol 1996;27:87-89.
11. Valteau-Couanet D, Kalifa C, Benhamou E, et al. Repeated high-dose chemotherapy (HDC) followed by stem cell transplantation (SCT) in young children with poor prognosis medulloblastoma (MB) or PNET: tolerance and efficacy. Proceedings. 8th International Symposium on Pediatric Neuro-Oncology, Rome, Italy, May 1998.
12. Mastrangelo R, Tornesello A, Piciacchia D, et al. Busulfan in childhood medulloblastoma/PNET: Feasibility of an "in vivo" sensitivity test prior to autologous bone marrow transplantation (ABMT). Proceedings, 8th International Symposium on Pediatric Neuro-Oncology. Rome, Italy, May 1998.
13. Tait DM, Thornton-Jones H, Bloom HJG, et al. Adjuvant chemotherapy for medulloblastoma: the first multicentre control trial of the International Society of Paediatric Oncology (SIOP I). Eur J Cancer 1990;26:464-469.
14. Evans AE, Jenkin DT, Sposto R, et al. The treatment of medulloblastoma. The results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine and prednisone. J Neurosurg 1990;72:572-582.
15. Donelli MG, Zucchetti M, D'Incalci M. Do anticancer agents reach the tumor target in the human brain? Cancer Chemother Pharmacol 1992;30:251-260.
16. Vassal G, Gouyette A, Hartmann O, et al. Pharmacokinetics of high-dose busulfan in children. Cancer Chemother Pharmacol 1989;24:386-390.
17. Finlay JL. The role of high-dose chemotherapy and stem cell rescue in the treatment of malignant brain tumors. Bone Marrow Transplant 1996;18:S1-S5.
18. Coldman AJ, Goldie JH. Role of mathematical modeling in protocol formulation in cancer chemotherapy. Cancer Treat Rep 1985;69:1041-1048.
19. Tornesello A, Mastrangelo S, Piciacchia D. Progressive disease in children with medulloblastoma/PNET during pre-radiation chemotherapy. J Neurooncol (in press).
20. Chao NJ, Kastrissios H, Long GD, et al. A new preparatory regimen for autologous bone marrow transplantation for patients with lymphoma. Cancer 1995;75:1354-1359.